One-Year Outcomes of a Treat-and-Extend Regimen of Aflibercept for Exudative Age-Related Macular Degeneration

Publisher： Karger

E-ISSN： 1423-0267|237|3|139-144

ISSN： 0030-3755

Source： Ophthalmologica, Vol.237, Iss.3, 2017-03, pp. : 139-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

One-Year Outcomes of the Treat-and-Extend Approach with Aflibercept in Age-Related Macular Degeneration: Effects on Typical Choroidal Neovascularization and Retinal Angiomatous Proliferation

By  

Ophthalmologica, Vol. 236, Iss. 4, 2016-12 ,pp. : 215-222

Karger

Access to resources Recommend Favorite

Outcomes when Switching from a pro re nata Regimen to a Treat and Extend Regimen Using Aflibercept in Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 236, Iss. 4, 2016-12 ,pp. : 201-206

Karger

Access to resources Recommend Favorite

Baseline Optical Coherence Tomography Findings as Outcome Predictors after Switching from Ranibizumab to Aflibercept in Neovascular Age-Related Macular Degeneration following a Treat-and-Extend Regimen

By  

Ophthalmologica, Vol. 238, Iss. 3, 2017-08 ,pp. : 172-178

Karger

Access to resources Recommend Favorite

One-Year Outcomes of 1 + pro re nata versus 3 + pro re nata Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 237, Iss. 2, 2017-02 ,pp. : 105-110

Karger

Access to resources Recommend Favorite

Fluctuations in Pigment Epithelial Detachment and Retinal Fluid Using a Bimonthly Treatment Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 235, Iss. 1, 2016-0 ,pp. : 42-48

Karger

Access to resources Recommend Favorite